Latest vascular diseases Stories
HELMOND, The Netherlands, October 30, 2012 /PRNewswire/ -- Innovator in the treatment of vascular diseases launches non compliant DEB worldwide Blue Medical, the global medical device company and innovator in the treatment of vascular diseases, today announced receiving the CE mark for Protege NC, a non compliant drug eluting balloon. The new device will be launched worldwide. It follows the introduction of Blue Medical's CE marked Drug Eluting Balloon Protege and CoCr...
HELMOND, The Netherlands, August 23, 2012 /PRNewswire/ -- Former Director of eLEAF, Noel Coopmans, joins rapid growing innovator in the treatment of vascular diseases Blue Medical, the global medical device company and innovator in the treatment of vascular diseases, today announces the appointment of Noel Coopmans as Blue Medical's CEO. Noel Coopmans brings more than 15 years of relevant business experience to his new role. Former CEO and founder of the company, Ronald...
One of the top suspects behind killer vascular diseases is the victim of mistaken identity, according to researchers from the University of California, Berkeley, who used genetic tracing to help hunt down the real culprit. The guilty party is not the smooth muscle cells within blood vessel walls, which for decades was thought to combine with cholesterol and fat that can clog arteries. Blocked vessels can eventually lead to heart attacks and strokes, which account for one in three deaths in...
Vascular Disease Foundation's Julius H. Jacobson II MD Award for Physician Excellence Recognizes Outstanding Contributions of Barry T. Katzen, M.D., FSIR, to Physician Education, Leadership and Patient Care in Vascular Diseases FAIRFAX, Va., Oct. 4, 2011 /PRNewswire-USNewswire/ -- Society of Interventional Radiology member Barry T. Katzen, M.D., FSIR, an interventional radiologist and founder and medical director of Baptist Cardiac & Vascular Institute in Miami, Fla., was awarded this...
2011 Vascular Disease Foundation Award Winners Announced at Annual Meeting WASHINGTON, Sept. 23, 2011 /PRNewswire-USNewswire/ -- The Vascular Disease Foundation (VDF) presented its annual awards at the organization's eighth annual meeting in Washington. The awards honor the work of citizens, health care providers, organizations, researchers and companies that have enhanced the understanding and/or treatment of peripheral vascular diseases. (Logo:...
A drug that has been on the market for decades to treat leukemia and skin disorders such as acne and psoriasis may be a possible therapy for vascular diseases, including atherosclerosis and hypertension, which can lead to heart attack or stroke.Previously, researchers discovered that retinoids "“ commonly used natural or man-made drugs related to vitamin A "“ blunted experimental vascular disease by spurring into action a very particular segment of a gene known for its ability to curb...
They are the most widely produced fruit in the world and now scientists in Japan have discovered that tomatoes contain a nutrient which could tackle the onset of vascular diseases. The research, published in the journal Molecular Nutrition & Food Research, reveals that an extracted compound, 9-oxo-octadecadienoic, has anti-dyslipidemic affects.The team led by Dr Teruo Kawada, from Kyoto University and supported by the Research and Development Program for New Bio-industry Initiatives,...
FT. LAUDERDALE, Fla. and HONG KONG, Dec. 1, 2010 /PRNewswire/ -- OrbusNeich Medical, Inc. ("OrbusNeich" or the "Company"), a designer, developer, manufacturer and marketer of innovative medical devices for the treatment of vascular diseases, today issued a statement regarding unsuccessful retaliatory litigation efforts by Boston Scientific Corporation (NYSE: BSX) against OrbusNeich in The Netherlands. In March 2009, OrbusNeich filed a lawsuit in the United States asserting claims against...
